General MedicationsORALStandard
READI-CAT 2 SMOOTHIE
BARIUM SULFATE
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary
Approval overview READI-CAT 2 SMOOTHIE is listed in Drugs@FDA under application 208143 (NDA).
Review priority: N/A Marketing status: Prescription Active ingredient BARIUM SULFATE Form and strength SUSPENSION;ORAL - 2% Sponsor BRACCO Submission history Latest submission status date: 2022-03-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview READI-CAT 2 SMOOTHIE is listed in Drugs@FDA under application 208143 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient BARIUM SULFATE Form and strength SUSPENSION;ORAL - 2% Sponsor BRACCO Submission history Latest submission status date: 2022-03-10 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.